Delta FosB (D3S8R) Rabbit mAb #14695
- WB
- IP
Supporting Data
REACTIVITY | H M R Mk |
SENSITIVITY | Endogenous |
MW (kDa) | 37 |
Source/Isotype | Rabbit IgG |
Application Key:
- WB-Western Blotting
- IP-Immunoprecipitation
Species Cross-Reactivity Key:
- H-Human
- M-Mouse
- R-Rat
- Mk-Monkey
Product Information
Product Usage Information
Application | Dilution |
---|---|
Western Blotting | 1:1000 |
Immunoprecipitation | 1:50 |
Storage
Protocol
Specificity / Sensitivity
Species Reactivity:
Source / Purification
Background
The delta FosB protein is encoded by the FosB gene and is produced by alternative splicing. This shorter isoform lacks a carboxy-terminal FosB region that contains ubiquitination sites and results in more stable delta FosB protein (9). Induced delta FosB accumulates in select brain regions upon chronic drug use (10-12) where it interacts with JunD to form an active, long-lasting AP-1 complex (13). This complex may represent a molecular switch that helps initiate and maintain the addicted state (14,15).
- Tulchinsky, E. (2000) Histol Histopathol 15, 921-8.
- Dobrazanski, P. et al. (1991) Mol Cell Biol 11, 5470-8.
- Nakabeppu, Y. and Nathans, D. (1991) Cell 64, 751-9.
- Rosenberger, S.F. et al. (1999) J Biol Chem 274, 1124-30.
- Sasaki, T. et al. (2006) Mol Cell 24, 63-75.
- Basbous, J. et al. (2007) Mol Cell Biol 27, 3936-50.
- Kovary, K. and Bravo, R. (1991) Mol Cell Biol 11, 2451-9.
- Kovary, K. and Bravo, R. (1992) Mol Cell Biol 12, 5015-23.
- Carle, T.L. et al. (2007) Eur J Neurosci 25, 3009-19.
- Hope, B.T. et al. (1994) Neuron 13, 1235-44.
- Nye, H.E. et al. (1995) J Pharmacol Exp Ther 275, 1671-80.
- Nye, H.E. and Nestler, E.J. (1996) Mol Pharmacol 49, 636-45.
- Chen, J. et al. (1997) J Neurosci 17, 4933-41.
- Nestler, E.J. et al. (2001) Proc Natl Acad Sci U S A 98, 11042-6.
- McClung, C.A. et al. (2004) Brain Res Mol Brain Res 132, 146-54.
Limited Uses
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.